Phage Therapy Market Investment Trends and Funding Landscape
Investment activity in the phage therapy market has intensified as venture capital firms, government agencies, and strategic pharmaceutical partners recognize the commercial potential of bacteriophage-based therapeutics. The market has attracted substantial funding rounds, highlighted by USD 50 million in fresh capital that accompanied BiomX's acquisition of Adaptive Phage Therapeutics in March...
0 Commentarii 0 Distribuiri 6 Views 0 previzualizare